A unique opportunity to learn face-to-face from internationally recognised pricing experts with excellent training competencies
We host tailored events with industry experts, fostering a vibrant community and offering unparalleled networking opportunities. EPP Events provide the knowledge and connections necessary for excelling in the monetization game within your industry.
EPP Webinars are non-sales events designed to immerse you in the latest insights, tools, and best practices on emerging topics.
Access an extensive collection of digital publications to enhance your professional growth
Discover pricing content curated by our partners - your ultimate resource for excpert insights on effective pricing strategies
In the days before 2020 came to a close, China’s National Healthcare Security Administration (NHSA) and Ministry of Human Resources and Social Security (MOHRSS) issued the 2020 Edition of the National Reimbursement Drug List (NRDL).
This year, PD-1 inhibitors — a category of drugs that are often costly yet highly effective — were the hot issue between multinational corporations (MNCs) and domestic businesses. When the negotiations came to a close, home-grown PD-1 efforts from Shanghai Junshi Biosciences, BeiGene Ltd. and Jiangsu Hengrui Medicine took the coveted spots from household names like Roche, Bristol Myers Squibb, AstraZeneca and MSD.